Rhusipathiae丹毒丝菌
病菌
医学
微生物学
抗生素
免疫学
琼脂平板
人畜共患病
全血
细菌
病理
聚合酶链反应
超抗原
氧氟沙星
生物
作者
Yu Zhang,Amin Yao,Pingfang Yan,JM Wen,Liang Li,Y Xu
标识
DOI:10.1684/ejd.2026.4986
摘要
Septicaemic erysipeloid caused by Erysipelothrix rhusiopathiae is a rare zoonosis with high mortality. Hepatic injury as a complication has never been documented, and quantitative monitoring of pathogen clearance dynamics remains unexplored. To investigate the clinical characteristics of liver function damage caused by septicaemic erysipeloid, and explore reasonable diagnosis and treatment strategies. The clinical data of a 46-year-old male patient with liver function damage caused by septicaemic erysipeloid are summarized. Blood agar plate culture, drug sensitivity test, and a PCR method were used to detect the presence of Erysipelothrix rhusiopathiae in the blood and to dynamically monitor the results of drug treatment. Erysipelothrix rhusiopathiae was detected in blood cultures and confirmed by PCR. Longitudinal molecular monitoring revealed a progressive decline in bacterial load during treatment (day 0 to day 10), demonstrating significant antibiotic efficacy (p<0.01). By day 10, bacterial levels showed no significant difference compared to the negative control group (p>0.05). This study is the first to delineate the pathogen clearance kinetics of septicaemic erysipeloid through longitudinal molecular monitoring, providing a quantitative basis for therapeutic efficacy evaluation.
科研通智能强力驱动
Strongly Powered by AbleSci AI